Skip to main content
Clinical Trials/NCT01954277
NCT01954277
Completed
Phase 2

Immune-Pineal Axis Function in Chronic Tension-Type Headache: Noradrenergic Modulation and the Effect of Electroacupuncture

Hospital de Clinicas de Porto Alegre1 site in 1 country34 target enrollmentOctober 2010

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Chronic Tension-Type Headache
Sponsor
Hospital de Clinicas de Porto Alegre
Enrollment
34
Locations
1
Primary Endpoint
Pain Visual Analogue Scale (VAS)
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

The purpose of this study is to determine whether electroacupuncture is effective in the treatment of chronic tension-type headache, measured by Headache Impact Test, Visual Analogue Scale and biomarkers.

Detailed Description

Tension-type headache can be defined as a constant sensation of pressure or heaviness, and is a highly-prevalent condition in the health services. The objective of the present study is to investigate the function of the immuno-pineal axis in chronic tension headache, focussed on the neuro-immune regulatory dysfunction. In addition, the effect of neuro-stimulation (electroacupuncture) on the function of this axis will also be studied. This is a clinical Trial study, randomised, in parallel, cross-over with a blinded assessor, and with a sham placebo control. The study will be carried out in the Clinical Research Outpatient Clinic of the Hospital de Clínicas de Porto Alegre (HCPA), with women aged between 18 and 60 years old. The participants will respond to questionnaires at the beginning and end of each therapeutic intervention, with 24-hour urine, blood and saliva collection. The therapeutic intervention will include: 10 electroacupuncture sessions and 10 sham placebo sessions. The measurements taken will be: quality of life, depression, impact of headache on daily life, sleep quality, chronotropic types, immuno-inflammatory mediators, levels of 6-sulfatoxymelatonin, and salivary cortisol. Through these interventions it is hoped that patients will present an improvement in their pain presentation, quality of life and sleep, as well as central autonomic regulation. Evidence for these hypotheses will support a minimally-invasive treatment, with few side-effects and a low cost.

Registry
clinicaltrials.gov
Start Date
October 2010
End Date
November 2013
Last Updated
12 years ago
Study Type
Interventional
Study Design
Crossover
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Wolnei Caumo

MD, PhD, Professor and coordinator of Pain & Neuromodulation Lab

Hospital de Clinicas de Porto Alegre

Eligibility Criteria

Inclusion Criteria

  • Aged between 18 and 60 years old,
  • Providing informed consent to participate in the study,
  • Literate,
  • Clinical diagnosis of Chronic Tension-Type Headache according to the International Headache Society.

Exclusion Criteria

  • Psychiatric or neurologic disorder that unable patient to consent and follow study protocol,
  • De-compensated systemic disease,
  • Chronic inflammatory disease (e.g. Systemic Lupus Erythematous, Rheumatoid Arthritis),

Outcomes

Primary Outcomes

Pain Visual Analogue Scale (VAS)

Time Frame: An expected average of 3 months. (At baseline and at the end of each intervention period).

The intensity of pain was measured by a 10 cm VAS. The scores range from no pain (zero) to the worst possible pain (10 cm).

Secondary Outcomes

  • Headache Impact Test (HIT-6)(An expected average of 3 months. (At baseline and at the end of each intervention period).)

Study Sites (1)

Loading locations...

Similar Trials